(NASDAQ: DTIL) Precision Biosciences's forecast annual revenue growth rate of 1.12% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 50.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.79%.
Precision Biosciences's revenue in 2025 is $75,096,000.On average, 1 Wall Street analysts forecast DTIL's revenue for 2025 to be $349,800,290, with the lowest DTIL revenue forecast at $349,800,290, and the highest DTIL revenue forecast at $349,800,290. On average, 1 Wall Street analysts forecast DTIL's revenue for 2026 to be $510,125,424, with the lowest DTIL revenue forecast at $510,125,424, and the highest DTIL revenue forecast at $510,125,424.
In 2027, DTIL is forecast to generate $580,699,166 in revenue, with the lowest revenue forecast at $580,699,166 and the highest revenue forecast at $580,699,166.